Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Pressemeddelelse

Cell Impact reports first quarter results: continued strong sales

Cell Impact

CELL IMPACT REPORTS FIRST QUARTER RESULTS: CONTINUED STRONG SALES

Cell Impact AB (Nasdaq First North GM: CI B) reports the following financial summary for the first quarter.

  • Total revenues for the first quarter amounted to SEK 21.7 million, which is growth of 74% for the quarter.
  • Operating result was SEK -23.9 million (-14.4) during the quarter.
  • The Group's result for the quarter after financial items was SEK -24.1 million (-14.7).
  • Earnings per share attributable to the shareholders of the Parent Company totaled SEK -0.32 (-0.25) during the quarter.
  • Equity was SEK 401.5 million (187.2) or SEK 5.31 per share (3.18) on the balance sheet date.
  • Debt/equity ratio was 87% (78%) on the balance sheet date.
  • Cash flows from operating activities amounted to SEK -10.5 million (-8.2) during the quarter.
  • On the balance sheet date, the Group's cash and cash equivalents totaled SEK 280.1 million (129.8).

For more information, please contact:

Stefan Axellie, CFO, +46 70-343 46 55 or stefan.axellie@cellimpact.com.

The following documents can be retrieved from beQuoted
Cell Impact PressRelease EN 20220506.pdf
CellImpact 2022Q1 EN F.pdf

About Cell Impact

Cell Impact AB (publ) is a global supplier of advanced flow plates to fuel cell manufacturers. The company has developed and patented a unique method for high-velocity forming, Cell Impact Forming™, which makes it possible to produce flow plates with more advanced designs, which in turn creates more cost and energy-efficient fuel cells compared to conventional forming methods.

The Cell Impact share is listed on Nasdaq First North Growth Market and FNCA Sweden AB is the company's Certified Advisor (CA). Contact info: +46 8-528 00 399 or info@fnca.se.

This information is inside information that Cell Impact AB is obliged to make public pursuant to the EU Market Abuse Regulation.

Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.